# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Prenetics announces David Beckham as a strategic investor and co-founding partner of IM8, a new health and wellness brand. IM8 ...
Prenetics, (NASDAQ:PRE) a leading health sciences company, is proud to announce that former international footballer, entrepren...
Prenetics Global (NASDAQ:PRE) reported quarterly losses of $(0.70) per share. This is a 44 percent increase over losses of $(1....
Cantor Fitzgerald analyst Ross Osborn maintains Prenetics Global (NASDAQ:PRE) with a Overweight and lowers the price target ...